(CercleFinance.com) – BlackRock and QLS Advisors, a life science advisory and technology firm, announced a partnership through BlackRock Systematic to develop data-driven investment solutions for help accelerate biomedical innovation.
The partnership will leverage the two companies’ combined experience in research and development and investment, directing funding to public and private companies that have the potential to create transformative therapies, while seeking to secure attractive returns on investment for customers’ indicates the group.
‘ This methodology, combined with BlackRock Systematic’s global platform, proprietary analytics and over 35 years of data-driven investing experience, presents a differentiated approach to investing in life sciences companies. life ‘adds BlackRock.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
